Human Papillomavirus And Oropharyngeal Cancer Stage.
Maura L. Gillison
Published 2016 · Medicine
Download PDFAnalyze on Scholarcy
This paper references
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
Danny Rischin (2010)
Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more accurate predictions than TNM staging.
Emmanuel Rios Velazquez (2014)
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Lisa Licitra (2006)
Human papillomavirus and survival of patients with oropharyngeal cancer.
K Kian Ang (2010)
Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
Matthew Alex Ward (2015)
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
B O'Sullivan (2013)
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Shao Hui Huang (2015)
Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
Lauren C Das (2015)
An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair.
Kristina R Dahlstrom (2013)
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Pernille Lassen (2009)
Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers.
Maura L. Gillison (2006)
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.
Marshall R. Posner (2011)
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.
Maura L. Gillison (2012)
Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
Florence K. Keane (2015)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B Edge (2010)
Human papillomavirus genotype and oropharynx cancer survival in the United States of America.
Marc T. Goodman (2015)
Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.
Kristina R Dahlstrom (2016)
This paper is referenced by
Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
Anna Kaisa Kylmä (2020)
A Descriptive, Longitudinal Study of Quality of Life and Perceived Health Needs in Patients With Head and Neck Cancer
S. Kate Sandstrom (2016)
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging
John M Floberg (2018)
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
David Adelstein (2017)
In HPV-negative oropharyngeal squamous cell carcinoma, elevated toll-like receptor 2 immunoexpression may increase the risk of disease-specific mortality.
Anna Kaisa Kylmä (2020)
Oropharyngeal squamous cell carcinoma induces an innate systemic inflammation, affected by the size of the tumour and the lymph node spread
Å Kågedal (2018)
HPV Vaccination, Sociodemographic Variables, and Physician Recommendation in Select U.S. Areas
Rebecca M. Jungbauer (2017)
DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma
Eric A. Smith (2017)
Treponema denticola chymotrypsin-like protease as associated with HPV-negative oropharyngeal squamous cell carcinoma
Anna Kaisa Kylmä (2018)